|
|
|
|
BioAnalab Ltd
BioAnaLab is a highly specialised clinical research organisation focused on supplying an analytical service to companies with therapeutic monoclonal antibodies in clinical development. The company plans to broaden its services to include other biopharmaceuticals including vaccines. Biopharmaceuticals, particularly monoclonal antibodies, are a rapidly growing sector of the pharmaceutical industry.
These drugs are among the most effective new treatments for a wide range of diseases. They also bring many new challenges, including the need to develop methods to measure drug levels, patient responses and efficacy. BioAnaLab is developing tests to enhance the safety and utility of these new therapeutics and presents a unique service to assist in their development and marketing. The hallmarks of the BioAnaLab service are:
. Quality and attention to regulatory compliance
.
Strong scientific and clinical backup from an experienced panel of advisors
.
Responsiveness to clients timelines o A team of experienced scientists using well-established and validated technologies
The methods currently available focus on the measurement of antibodies and antigens in blood samples and may be applied to:
Therapeutic or diagnostic monoclonal antibodies and derivatives
Other protein-based therapeutics, such as cytokines, growth factors etc
Vaccines
Platform Technologies
Analytical methods are used intensively during drug development, to characterise pharmacokinetics, biodistribution and potential adverse effects. Many are required throughout the product lifetime. For example, it may be necessary to adjust dosage because of differences in metabolism or disease response, so accurate measures of drug levels and markers of efficacy are needed.Antibody responses to protein-based drugs need to be checked, especially in patients who are eligible for repeat treatments. Other tests can assess the likely responsiveness of a patient in advance of treatment, allowing therapy to be more specifically tailored, reducing side effects and leading to increased compliance and cost effectiveness.
Areas for Potential Collaboration
Please contact us to discuss any potential opportunity.
|
|
|
|
NEW SERVICE !
|
PRODUCT AWARD
|
|
PERSPECTIVES
|
|
OFFICIAL PARTNERS
|
|
|
